Medical Use
Leqvio (inclisiran) is a small interfering RNA (siRNA) that targets PCSK9 mRNA to lower cholesterol levels in the blood. It is prescribed for adults with primary hypercholesterolemia or mixed dyslipidemia, conditions characterized by high levels of fats, including cholesterol. A low-fat diet should be followed while taking Leqvio. It is used alongside a statin when the maximum dose of the statin is insufficient to lower cholesterol levels. It can also be combined with other cholesterol-lowering medications for individuals who cannot take statins.
Recommended Dosage:
- -Initial Dose: The recommended dose of Leqvio is 284 mg, administered as a subcutaneous injection.
- -Subsequent Doses: The next dose is given three months after the initial dose, followed by doses every six months.
Before starting Leqvio, patients should be on a cholesterol-lowering diet and likely taking a cholesterol-lowering medication. They should continue this diet and medication throughout the treatment with Leqvio.
Administration Instructions:
- -Inject Leqvio subcutaneously into the upper arm, abdomen, or thigh.
- -Avoid injecting into areas with active skin conditions such as inflammation, rashes, infections, or sunburn.
Missed Dose Instructions:
- -If a dose is missed and it is less than three months since the last dose, administer the missed dose and continue with the regular dosing schedule.
- -If more than three months have passed since the last dose, restart the dosing schedule: administer the initial dose, follow with a dose at three months, and then continue with doses every six months.
Warning & Precautions
The effect of haemodialysis on Leqvio pharmacokinetics has not been studied. Given that Leqvio is eliminated from the body, haemodialysis should not be performed for at least 72 hours after administering Leqvio.
Pregnancy and Leqvio: There is limited data on the use of Leqvio in pregnant women. Animal studies have not shown direct or indirect harmful effects on reproduction. However, as a precaution, Leqvio 284 mg injection should be avoided during pregnancy.
Breastfeeding and Leqvio: It is not known if Leqvio is excreted in human milk. Animal studies have shown that the drug is excreted in milk. Therefore, there is a potential risk to infants. As a precaution, breastfeeding should be avoided during treatment with Leqvio.
Driving and Operating Machinery: Leqvio injection (284 mg/1.5 mL, 189 mg/mL) has no or negligible effect on the ability to drive and operate machinery
Documentation Availability
Documents required to import LEQVIO to India?
LEQVIO (inclisiran) injections can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing LEQVIO (Cancer Treatment Medicines) from around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the Generic Name for Leqvio®?
The generic name for Leqvio® is Inclisiran.
Who manufactures Leqvio®?
Leqvio® is manufactured by Novartis Pharmaceuticals Corporation.
Is Leqvio® FDA approved?
Yes, Leqvio® was approved by the FDA on December 22, 2021.
Where can I find the best price for Leqvio® in India?
For the best price on Leqvio in India, contact the Rx4U team.
What are the available dosages and forms of Leqvio®?
Leqvio® is available as an injection: 284 mg/1.5 mL (189 mg/mL) in a single-dose prefilled syringe for subcutaneous administration.
What are the common side effects of Leqvio®?
Common side effects include arthralgia, injection site reactions, urinary tract infections, diarrhea, bronchitis, dyspnea, and pain in the extremities.
How much does Leqvio cost in India?
The cost of Leqvio in India can vary. To purchase this medication legally, you can reach out to Rx4u team.
What are the storage conditions for Leqvio®?
Store Leqvio® at a controlled room temperature of 20-25°C (68-77°F), with allowable excursions between 15°C and 30°C (59°F and 86°F).
Is it safe to buy Leqvio® online in India?
Yes, you can safely purchase Leqvio® online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
